Optimization of FDG PET study after mRNA COVID-19 vaccination to reduce the interference of vaccine-associated hypermetabolic lymphadenopathy

Issued Date

2022-03-01

Resource Type

Letter

ISSN

09147187

eISSN

18646433

DOI

10.1007/s12149-021-01712-6

Scopus ID

2-s2.0-85123831337

Pubmed ID

35094260

Journal Title

Annals of Nuclear Medicine

Volume

36

Issue

3

Start Page

327

End Page

328

Rights Holder(s)

SCOPUS

Bibliographic Citation

Annals of Nuclear Medicine Vol.36 No.3 (2022) , 327-328

Suggested Citation

Thaweerat W. Optimization of FDG PET study after mRNA COVID-19 vaccination to reduce the interference of vaccine-associated hypermetabolic lymphadenopathy. Annals of Nuclear Medicine Vol.36 No.3 (2022) , 327-328. 328. doi:10.1007/s12149-021-01712-6 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/86081

Title

Optimization of FDG PET study after mRNA COVID-19 vaccination to reduce the interference of vaccine-associated hypermetabolic lymphadenopathy

Author(s)

Thaweerat W.

Author's Affiliation

Siriraj Hospital

Other Contributor(s)

Mahidol University

Keyword(s)

Medicine

Availability

URI

https://repository.li.mahidol.ac.th/handle/123456789/86081

Collections

Scopus 2022